Relay Therapeutics (RLAY) Asset Utilization Ratio (2020 - 2025)
Relay Therapeutics (RLAY) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.02 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio rose 114.05% to 0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02, a 114.05% increase, with the full-year FY2025 number at 0.02, up 76.33% from a year prior.
- Asset Utilization Ratio was 0.02 for Q4 2025 at Relay Therapeutics, up from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.04 in Q2 2024 to a low of 0.0 in Q2 2023.
- A 5-year average of 0.01 and a median of 0.01 in 2021 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: skyrocketed 21617.22% in 2021, then tumbled 78.07% in 2025.
- Relay Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then plummeted by 66.23% to 0.0 in 2022, then skyrocketed by 2296.6% to 0.03 in 2023, then plummeted by 61.93% to 0.01 in 2024, then skyrocketed by 114.05% to 0.02 in 2025.
- Per Business Quant, the three most recent readings for RLAY's Asset Utilization Ratio are 0.02 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).